Akso Health Group ADR (AHG)vsHong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)
AHG
Akso Health Group ADR
$1.34
-8.22%
HEALTHCARE · Cap: $1.15B
HKPD
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
$0.49
-2.06%
HEALTHCARE · Cap: $9.28M
Smart Verdict
WallStSmart Research — data-driven comparison
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares generates 10% more annual revenue ($16.36M vs $14.84M). AHG leads profitability with a 0.0% profit margin vs -4.3%. HKPD earns a higher WallStSmart Score of 27/100 (F).
AHG
Avoid16
out of 100
Grade: F
HKPD
Avoid27
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+18.0%
Fair Value
$1.72
Current Price
$1.34
$0.38 discount
Intrinsic value data unavailable for HKPD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Areas to Watch
0.9% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Smaller company, higher risk/reward
Operating margin of 3.0%
Weak financial health signals
ROE of -17.2% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : AHG
The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.
Bull Case : HKPD
The strongest argument for HKPD centers on Price/Book, Altman Z-Score.
Bear Case : AHG
The primary concerns for AHG are Revenue Growth, EPS Growth, Market Cap.
Bear Case : HKPD
The primary concerns for HKPD are Market Cap, Operating Margin, Piotroski F-Score.
Key Dynamics to Monitor
AHG profiles as a value stock while HKPD is a turnaround play — different risk/reward profiles.
AHG is growing revenue faster at 0.9% — sustainability is the question.
AHG generates stronger free cash flow (3M), providing more financial flexibility.
Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
HKPD scores higher overall (27/100 vs 16/100). AHG offers better value entry with a 18.0% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Akso Health Group ADR
HEALTHCARE · MEDICAL DISTRIBUTION · China
Akso Health Group ADR is a leading innovator in the healthcare sector, focused on delivering advanced medical solutions and comprehensive patient care services. The company harnesses state-of-the-art health technologies to drive growth in areas such as telehealth and personalized medicine, supported by a strong emphasis on research and development. With a resilient business model and a dedicated team, Akso Health Group presents an attractive investment opportunity for institutional investors, poised to capitalize on the ongoing transformation within the healthcare industry.
Visit Website →Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Hong Kong Pharma Digital Technology Holdings Limited is a pioneering entity in the biotechnology and digital healthcare sectors, focused on enhancing patient outcomes through innovative pharmaceutical services. By harnessing cutting-edge digital technologies and sophisticated data analytics, the company optimizes drug development and boosts operational efficiencies, positioning itself as a key player in the dynamic healthcare landscape. With a commitment to health technology advancement and strategic collaborations, Hong Kong Pharma is well-equipped to meet the evolving needs of both domestic and international markets while propelling innovation within its extensive service offerings.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?